Cost effectiveness and resource allocation : C/E

Keyphrases

Publications

volume 22, number 1, 2024

Mehran Faraji, Tahereh Sharifi, Saeed Mohammad-Pour, Javad Javan-Noughabi, Ali Aboutorabi, Shaghayegh Yousefi, Mihajlo Jakovljevic
Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jiahui Li, Chaoqun Xu, Suyun Yuan
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Ehsan Jozaghi
A new innovative method to measure the cost of war: future with fewer conflicts via harm reduction approaches. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Susan de Jersey, Syed Afroz Keramat, Angela Chang, Nina Meloncelli, Taylor Guthrie, Elizabeth Eakin, Tracy Comans
A cost-effectiveness evaluation of a dietitian-delivered telephone coaching program during pregnancy for preventing gestational diabetes mellitus. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Majid Nakhaee, Masoud Khandehroo, Reza Esmaeili
Cost of illness studies in COVID-19: a scoping review. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Tianyi Liu, Yiyang Zhan, Silei Chen, Wenhong Zhang, Jian Jia
Correction: Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Julia Bidonde, Vigdis Lauvrak, Aparna Ananthakrishnan, Pritaporn Kingkaew, Elizabeth F Peacocke
Topic identification, selection, and prioritization for health technology assessment in selected countries: a mixed study design. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Yusi Tu, Xiangyan Tang, Dachuang Zhou, Hanqiao Shao, Leyi Liang, Wenxi Tang
Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C? Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Stavros Petrou, Mihajlo Michael Jakovljevic
Reimagining the relationship between economics and health- WHO 'Health for all' provisions. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Stavros Petrou, Mihajlo Michael Jakovljevic
Reimagining the relationship between economics and health- WHO 'Health for all' provisions. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Yu Seong Hwang, Woo Jin Kim, Tae Hyun Kim, Yukyung Park, Su Mi Jung, Heui-Sug Jo
Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Mohammed Khaled Al-Hanawi, Naseem Al Rahahleh
Mitigating role of financial inclusion on the perceived difficulties, concerns, and borrowing for medical expenses in Saudi Arabia. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Susan de Jersey, Syed Afroz Keramat, Angela Chang, Nina Meloncelli, Taylor Guthrie, Elizabeth Eakin, Tracy Comans
A cost-effectiveness evaluation of a dietitian-delivered telephone coaching program during pregnancy for preventing gestational diabetes mellitus. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Tianyi Liu, Yiyang Zhan, Silei Chen, Wenhong Zhang, Jian Jia
Correction: Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Zahra Goudarzi, Rahil Sadat Shahtaheri, Zhila Najafpour, Haleh Hamedifar, Hamidreza Ebrahimi
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Di Song, Liwen Wang
Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Di Song, Liwen Wang
Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Wolf Rogowski, Jürgen John
Preferences as fairness judgments: a critical review of normative frameworks of preference elicitation and development of an alternative based on constitutional economics. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Areej S Albahdal, Amjad M Alotaibi, Miteb A Alanazi, Norah Abanmy, Monira Alwhaibi, Yazed AlRuthia
Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jing Nie, Huina Wu, Qian Wu, Lihui Liu, Ke Tang, Shuo Wang, Jiyong Wu
Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jing Nie, Huina Wu, Qian Wu, Lihui Liu, Ke Tang, Shuo Wang, Jiyong Wu
Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Cost-utility of tiotropium in patients with severe asthma. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jing Nie, Huina Wu, Qian Wu, Lihui Liu, Ke Tang, Shuo Wang, Jiyong Wu
Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Mohammed Khaled Al-Hanawi, Naseem Al Rahahleh
Mitigating role of financial inclusion on the perceived difficulties, concerns, and borrowing for medical expenses in Saudi Arabia. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Majid Nakhaee, Masoud Khandehroo, Reza Esmaeili
Cost of illness studies in COVID-19: a scoping review. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jihyung Hong, Eun-Young Bae, Hye-Jae Lee, Tae-Jin Lee, Philip Clarke
Values, challenges, and responses associated with high-priced potential cures: perspectives of diverse stakeholders in South Korea. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Chakib Boukhalfa, Brahim Ouakhzan, Hanane Masbah, Leila Acharai, Saad Zbiri
Investing in midwifery for sustainable development goals in low- and middle-income countries: a cost-benefit analysis. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Yu Seong Hwang, Woo Jin Kim, Tae Hyun Kim, Yukyung Park, Su Mi Jung, Heui-Sug Jo
Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Susan de Jersey, Syed Afroz Keramat, Angela Chang, Nina Meloncelli, Taylor Guthrie, Elizabeth Eakin, Tracy Comans
A cost-effectiveness evaluation of a dietitian-delivered telephone coaching program during pregnancy for preventing gestational diabetes mellitus. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jihyung Hong, Eun-Young Bae, Hye-Jae Lee, Tae-Jin Lee, Philip Clarke
Values, challenges, and responses associated with high-priced potential cures: perspectives of diverse stakeholders in South Korea. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Zahra Goudarzi, Rahil Sadat Shahtaheri, Zhila Najafpour, Haleh Hamedifar, Hamidreza Ebrahimi
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Zahra Goudarzi, Rahil Sadat Shahtaheri, Zhila Najafpour, Haleh Hamedifar, Hamidreza Ebrahimi
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Mehran Faraji, Tahereh Sharifi, Saeed Mohammad-Pour, Javad Javan-Noughabi, Ali Aboutorabi, Shaghayegh Yousefi, Mihajlo Jakovljevic
Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jihyung Hong, Eun-Young Bae, Hye-Jae Lee, Tae-Jin Lee, Philip Clarke
Values, challenges, and responses associated with high-priced potential cures: perspectives of diverse stakeholders in South Korea. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Di Song, Liwen Wang
Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Areej S Albahdal, Amjad M Alotaibi, Miteb A Alanazi, Norah Abanmy, Monira Alwhaibi, Yazed AlRuthia
Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Yusi Tu, Xiangyan Tang, Dachuang Zhou, Hanqiao Shao, Leyi Liang, Wenxi Tang
Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C? Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Areej S Albahdal, Amjad M Alotaibi, Miteb A Alanazi, Norah Abanmy, Monira Alwhaibi, Yazed AlRuthia
Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Ehsan Jozaghi
A new innovative method to measure the cost of war: future with fewer conflicts via harm reduction approaches. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Julia Bidonde, Vigdis Lauvrak, Aparna Ananthakrishnan, Pritaporn Kingkaew, Elizabeth F Peacocke
Topic identification, selection, and prioritization for health technology assessment in selected countries: a mixed study design. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Wolf Rogowski, Jürgen John
Preferences as fairness judgments: a critical review of normative frameworks of preference elicitation and development of an alternative based on constitutional economics. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Fan Zhaoyuan, Liu Xiaofeng
Retention of the highly educated migrants: from the perspective of urban e-service capability. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Stavros Petrou, Mihajlo Michael Jakovljevic
Reimagining the relationship between economics and health- WHO 'Health for all' provisions. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jiahui Li, Chaoqun Xu, Suyun Yuan
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Jefferson Antonio Buendia, Diana Guerrero Patiño
Cost-utility of tiotropium in patients with severe asthma. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Chakib Boukhalfa, Brahim Ouakhzan, Hanane Masbah, Leila Acharai, Saad Zbiri
Investing in midwifery for sustainable development goals in low- and middle-income countries: a cost-benefit analysis. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Chakib Boukhalfa, Brahim Ouakhzan, Hanane Masbah, Leila Acharai, Saad Zbiri
Investing in midwifery for sustainable development goals in low- and middle-income countries: a cost-benefit analysis. Cost effectiveness and resource allocation : C/E 22 (1) (2024)